ArticleScientific reports2026
Sustainable spectrofluorimetric determination of berberine in dietary supplements via Erythrosin B Ion-Pair complexation with mechanistic investigation, Box-Behnken optimization, and green chemistry assessment.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
A novel spectrofluorimetric method was developed for berberine determination in dietary supplements based on ion-pair complex formation with Erythrosin B. Spectroscopic characterization of Erythrosin B, berberine, and their complex revealed hypsochromic shift and hypochromic effect in UV-visible absorption upon complexation, with concentration-dependent fluorescence quenching at 555 nm (λex = 530 nm). Mechanistic investigations confirmed static quenching through ground-state complex formation, evidenced by decreasing Stern-Volmer constants with increasing temperature (3.68 × 105 to 2.77 × 105 M− 1 from 298 to 313 K) and bimolecular quenching rate constants exceeding the diffusion-controlled limit. Thermodynamic analysis indicated spontaneous, exothermic complexation driven by both enthalpic and entropic contributions. Moreover, Job’s method established 1:1 stoichiometry, while PM3 quantum mechanical calculations revealed multiple stabilizing interactions including hydrogen bonding (1.7 Å), electrostatic interaction (3.2 Å), and halogen bonding (3.9 Å). Subsequently, Box-Behnken design optimization elucidated the influence of pH, reagent concentration, buffer volume, and incubation time on fluorescence quenching efficiency and yielded optimal conditions (pH 6.4, Erythrosin B 13.0 µg/mL, buffer volume 1.1 mL, incubation time 6.0 min). The method was then validated according to ICH Q2(R2) guidelines, demonstrating excellent linearity (0.1–3.0 µg/mL, r2 = 0.9997), high sensitivity (LOD = 0.032 µg/mL), satisfactory accuracy (99.83%), and precision (RSD < 1.4%). Selectivity studies revealed cross-reactivity with structurally related quaternary alkaloids, rendering the method suitable for standardized berberine supplements but not crude botanical extracts. Furthermore, statistical comparison with HPLC reference methods confirmed method equivalence. Finally, environmental assessment using AGREE (0.75), MoGAPI (78), CaFRI (82), and BAGI (77.5) demonstrated the method superior sustainability through minimal solvent consumption, reduced waste generation, and elimination of toxic reagents, offering a practical and environmentally friendly alternative for routine berberine quality control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.